Brief BIO sketch: Emily Y. Chew, M.D.
Emily Chew is the Deputy Director of the Division of Epidemiology and Clinical Applications (DECA) and the Chief of Clinical Trials Branch, at the National Eye Institute, the National Institutes of Health in Bethesda, Maryland. Emily received her medical degree and her ophthalmology training at the U. of Toronto, School of Medicine, in Toronto, Canada. She completed her fellowship in Medical Retina at the Wilmer Eye Institute, the Johns Hopkins Medical Institutes and the U. of Nijmegen, the Netherlands.
Her research interest includes phase 1/2 clinical trials and epidemiologic studies in retinovascular diseases such as age-related macular degeneration, diabetic retinopathy, ocular diseases of von Hippel-Lindau Disease and others. She worked on large multi-centered phase 3 trials headed by the staff of DECA including the Early Treatment Diabetic Retinopathy Study, the Age-Related Eye Disease Study and the Age-Related Eye Disease Study 2, which she chairs. She also chairs the Actions to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study in participants with type 2 diabetes. Emily directs the clinical program in the Macular Telangiectasia Project (Mac Tel Project) which is an international study conducted in 22 clinics in 7 countries along with several basic science laboratories.
Emily directs the medical retina fellowship at the NEI, providing the clinical training as well as education in conducting clinical trials. She previously chaired the Retina Panel for the Preferred Practice Pattern for the American Academy of Ophthalmology from 1998 to 2011. She served on the editorial boards of Investigative Ophthalmology and Vision Science and she continues to serve on the editorial boards of Ophthalmology and Retina.